| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Olema Pharmaceuticals, Inc. (OLMA) has 17 insiders with recent SEC Form 4 filings, including 1 buy and 21 sells. OLMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 737.8K | $11.26M | - | |
| CEO | 275.0K | $4.20M | - | |
| Other | 250.0K | $3.82M | - | |
| Other | 139.7K | $2.13M | - | |
| Other | 106.3K | $1.62M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2024 | Graham G. Walmsley48 | Director | Buy | 700,761 | $6.75 | $4,730,136.75 | +99.0% | -27.5% | +430.9% | |
| Dec 11, 2024 | Harmon Cyrus72 | Director | Sell | 16,393 | $9.03 | $147,955.81 | -0.7% | -48.5% | +275.5% | |
| Dec 11, 2024 | Myles David C.69 | Ch. Discov. &Non-clin Dev Off | Sell | 26,066 | $9.01 | $234,916.00 | -1.4% | -48.5% | +275.5% | |
| Dec 11, 2024 | Zojwalla Naseem56 | Chief Medical Officer | Sell | 27,805 | $9.01 | $250,455.83 | -7.1% | -48.5% | +275.5% | |
| Dec 11, 2024 | Kovacs Shane William Charles66 | Ch. Operating &Financial Off. | Sell | 35,159 | $9.01 | $316,703.45 | -2.1% | -48.5% | +275.5% | |
| Dec 11, 2024 | Bohen Sean72 | President And CEO | Sell | 109,502 | $9.01 | $986,365.11 | -12.3% | -48.5% | +275.5% | |
| Aug 1, 2024 | Paradigm Biocapital Advisors LP | 10% Owner | Sell | 2,400,000 | $14.92 | $35,796,000.00 | -30.4% | -29.3% | -67.6% | |
| Jul 30, 2024 | Harmon Cyrus72 | Director | Sell | 5,000 | $15.57 | $77,871.98 | -0.3% | -24.5% | -67.4% | |
| Jul 11, 2024 | Harmon Cyrus72 | Director | Sell | 5,000 | $12.26 | $61,300.00 | -0.7% | -9.9% | -62.8% | |
| Jun 28, 2024 | Harmon Cyrus72 | Director | Sell | 20,000 | $10.77 | $215,400.00 | -2.6% | +12.9% | -57.3% |